Reseda, California
United States
19
2026-03-19
The entities that hold a legal rights for patent applications filed by inventor Low Jonathan D.:
Jonathan D. Low from Reseda, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#2 | 2024-09-12Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#3 | 2022-12-15KRAS G12C inhibitors and methods of using the same
#4 | 2021-06-17Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#5 | 2021-06-10HETEROCYCLIC COMPOUNDS AS DELTA-5 DESATURASE INHIBITORS AND METHODS OF USE
#6 | 2020-08-06Macrocyclic compounds that inhibit MCL-1 protein
#7 | 2020-07-23Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use
#8 | 2020-06-04Compounds that inhibit Mcl-1 protein
#9 | 2019-12-12Substituted piperazines as KRAS G12C inhibitors
#10 | 2019-11-14KRAS G12C inhibitors and methods of using the same
#11 | 2019-02-28Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#12 | 2018-10-11Compounds that inhibit MCL-1 protein
#13 | 2017-09-21CYCLOPROPYL FUSED THIAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USE
#14 | 2017-05-25Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
#15 | 2016-09-29Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
#16 | 2016-05-19Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
#17 | 2016-02-18Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
#18 | 2015-09-10PERFLUORINATED CYCLOPROPYL FUSED 1,3-OXAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USE
#19 | 2014-10-23Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
945767 ⎘